Organization
Drug Metabolism
1 abstract
Abstract
ARRY-162, A SELECTIVE, POTENT MEK1/2 INHIBITOR, SIGNIFICANTLY REDUCES EX VIVO IL-1 BETA AND TNF ALPHA; PRODUCTION IN NORMAL SUBJECTSOrg: Chemistry, Bar Ilan University, Ramat Gan, Israel, Biology Department, Bashkir State Medical University, Pharmacology Discovery Services Taiwan, Ltd., Translational Research Institute and Dermatology Institute, Drug Metabolism,